4//SEC Filing
BERTHELSEN SPENCER R 4
Accession 0000874015-23-000144
CIK 0000874015other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 5:17 PM ET
Size
7.7 KB
Accession
0000874015-23-000144
Insider Transaction Report
Form 4
BERTHELSEN SPENCER R
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-20$28.47/sh+11,250$320,288→ 140,147 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-06-20−11,250→ 0 totalExercise: $28.47From: 2014-07-01Exp: 2023-06-30→ Common Stock (11,250 underlying)
Holdings
- 70(indirect: by Daughter)
Common Stock
Footnotes (2)
- [F1]Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2023
- [F2]The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001181548
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 5:17 PM ET
- Size
- 7.7 KB